INDEPENDENT NEWS

ICPBIO Starts Production at New Facility

Published: Mon 20 Nov 2006 12:12 AM
Media Statement
20 November 2006
ICPBIO Starts Production at New Facility
* Plasma fractionation operations re-started on schedule in new plant
* Plans for bovine plasma processing to rise from two tonnes per week to up to 12 tonnes per week by January 2007
* New capacity will make ICPbio world’s largest chromatography processer of bovine plasma
Statement made by Dr Earl Stevens, Managing Director, ICP Biotechnology Limited
ICPbio is on schedule with its new manufacturing facility in Henderson, Waitakere City. Plasma fractionation operations restarted in the new factory over the weekend, as scheduled, following receipt of the required Government approvals late last week. The new facility will now operate 24 hours a day, seven days per week.
Initially the new plasma fractionation plant will process two tonnes a week of bovine plasma, and by late January 2007 the company plans to process up to 12 tonnes of bovine plasma per week.
Space freed up in the existing 26 Waipareira Avenue facility following the transfer of its plasma fractionation operations to the 37–39 Waipareira Avenue facility will be utilised for additional new biological products, to be extracted from other bovine tissues which are by-products of the New Zealand meat industry.
The 26 Waipareira Avenue facility continues to operate on a 12–16 hour per day, five to six day per week schedule, with the ability to also move to 24 hour a day operations as the business expands.
When operating closer to design capacity, the new manufacturing facility will make ICPbio the world’s largest chromatography fractionator (processor) of bovine plasma and position ICPbio to become the third largest producer of bovine albumin in the world.
Unlike other biotechnology companies, ICPbio’s success is not dependent on discovering and exploiting its own novel drug discovery intellectual property but instead focuses on the low risk, high return end of the biotechnology market – and adding significant value to NZ farming sector output. ICPbio manufactures the media, serums and biochemicals pharmaceutical and biotechnology companies use to make, test, store, and deliver their products.
ENDS

Next in Business, Science, and Tech

The Sky Is The Limit - Air New Zealand To Relaunch 14 International Routes In 16 Days
By: Air New Zealand
Update On Hidden Economy Real Estate Campaign
By: Inland Revenue Department
Consumer Confidence Plummets To Record Lows As Financial Pressures Mount
By: Westpac
NZ Economy: Prevailing Headwinds
By: BusinessNZ
Shared Cheese Heritage Should Be Shared Not Stripped
By: NZ Specialist Cheesemakers Assn
Download Weekly - $60 million for more rural connections
By: Digitl
View as: DESKTOP | MOBILE © Scoop Media